What is Laura Morrison's NPI number?

Laura Morrison's National Provider Identifier (NPI) is 1003003153, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Laura Morrison's specialty?

Laura Morrison is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Laura Morrison located?

Laura Morrison's practice location on file with NPPES is 904 7th Ave, Seattle, WA 98104-1132.

What is Laura Morrison's phone number?

The practice phone number listed in the NPPES registry for Laura Morrison is (206) 860-4691.

Does Laura Morrison accept Medicare?

Laura Morrison is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Laura Morrison's NPI active?

Yes — Laura Morrison's NPI (1003003153) is active in the NPPES registry as of the last update on 2018-06-01.

IndividualActiveAccepts Medicare

Laura Morrison, MD

NPI 1003003153 · Dermatology Physician · Seattle, WA

Laura Morrison, MD is a Dermatology Physician provider in Seattle, WA (NPI 1003003153).

Provider details

NPI number: 1003003153
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: MD
Sex: Female
Sole proprietor: No
License: ML20009098 (WA)

Practice location

904 7th Ave

Seattle, WA 98104-1132

Phone: (206) 860-4691

Fax: (206) 329-1261

Street-level locationGet directions

More WA providers

Mailing address

15906 Mill Creek Blvd

Mill Creek, WA 98012-1797

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense MD60421884 (WA)
Allopathic & Osteopathic Physicians
Diagnostic Radiology Physician2085R0202XLicense ML20009098 (WA)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(73/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
19 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
1,467 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	579	$7
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	222	$89
Destruction of Precancer Skin Growth, 1 Growth17000	216	$50
Destruction of Skin Growth, 1-14 Growths17110	121	$114
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	121	$126
Biopsy of Related Skin Growth, First Growth

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 10 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	106	46
Triamcinolone Acetonide	63	43
Fluorouracil	59	46
Clobetasol Propionate	54	35
Clindamycin Phosphate	24	14
Doxycycline Hyclate	22	—
Minoxidil	19	—
Mupirocin	18	16

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$161 across 7 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2007-10-02
Last updated: 2018-06-01

Frequently asked questions

What is Laura Morrison's NPI number?: Laura Morrison's National Provider Identifier (NPI) is 1003003153, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Laura Morrison's specialty?: Laura Morrison is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Laura Morrison located?: Laura Morrison's practice location on file with NPPES is 904 7th Ave, Seattle, WA 98104-1132.
What is Laura Morrison's phone number?: The practice phone number listed in the NPPES registry for Laura Morrison is (206) 860-4691.
Does Laura Morrison accept Medicare?: Laura Morrison is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Laura Morrison's NPI active?: Yes — Laura Morrison's NPI (1003003153) is active in the NPPES registry as of the last update on 2018-06-01.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	579	$7
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	222	$89
Destruction of Precancer Skin Growth, 1 Growth17000	216	$50
Destruction of Skin Growth, 1-14 Growths17110	121	$114
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	121	$126
Biopsy of Related Skin Growth, First Growth

Drug

Part D claims (2024)

Beneficiaries

Ketoconazole

106

Triamcinolone Acetonide

Fluorouracil

Clobetasol Propionate

Clindamycin Phosphate

Doxycycline Hyclate

—

Minoxidil

—

Mupirocin

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$161 across 7 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments